Target intelligence / Profile preview

Ribosomal protein L3 pseudogene 12 (RPL3P12)

Target
RPL3P12
Molecular classification
Other (Processed pseudogene)
01

Overview

RPL3P12 is a **processed pseudogene** that shares sequence similarity with the functional ribosomal protein L3 gene (RPL3), which encodes a structural protein component of the ribosome's large 60S subunit[3][5]. Processed pseudogenes like RPL3P12 typically arise from reverse transcription of mRNA and reintegration into the genome, but they lack the regulatory elements and open reading frames needed to produce functional protein. As such, RPL3P12 is **non-functional**, does not encode any protein, and has no known biological, pathological, or therapeutic significance. It is not considered a drug target or a biomarker.[4] **Important clarification:** - The functional ribosomal protein L3 (gene symbol **RPL3**) is **not the same as RPL3P12**. RPL3 is a core ribosomal protein involved in protein synthesis, whereas RPL3P12 is a **noncoding pseudogene** with no known biological activity or disease role.[3][5] - If you want structured information about the functional ribosomal protein L3, use "60S ribosomal protein L3" (**RPL3**) as the canonical name.[3][5] **Summary:** RPL3P12 is a non-protein-coding pseudogene and not considered a therapeutic target under any established drug discovery or disease context. Any structured database of drug targets should exclude RPL3P12 from its list of actual targets.

Other names
Ribosomal protein L3 pseudogene 12RPL3P12RP L3 pseudogene 12

Beyond the preview

Go deeper on Ribosomal protein L3 pseudogene 12 (RPL3P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L3 pseudogene 12 (RPL3P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call